Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01576172
Title Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
City of Hope South Pasadena South Pasadena California 91030 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 United States Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington Medical Center Seattle Washington 98195 United States Details
University of Wisconsin Women's Health Center Madison Wisconsin 53715 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field